Abstract
The classification, pathophysiology, and treatment of angioedema is reviewed. An overview of acquired and hereditary angioedema is presented with an interesting case report that illustrates the importance of recognition and perioperative management of hereditary angioedema to prevent a potentially fatal outcome.
MeSH terms
-
Anabolic Agents / therapeutic use
-
Angioedema* / genetics
-
Angioedema* / physiopathology
-
Angioedema* / therapy
-
Blood Transfusion
-
Child
-
Complement Activation
-
Complement C1 Inactivator Proteins / therapeutic use
-
Dental Care for Chronically Ill*
-
Female
-
Genetic Diseases, Inborn
-
Humans
-
Plasma
-
Stanozolol / therapeutic use
-
Tooth Extraction
Substances
-
Anabolic Agents
-
Complement C1 Inactivator Proteins
-
Stanozolol